13F Data
13F filer · CIK 1646343

NEXTHERA CAPITAL LP

NEW YORK, NY · filing since Q4 2015 · last filing Aug 14, 2019
Reported value
$120.1M
+$37.7M vs prior
Positions
23
New / sold out
11 / 12
Added / reduced
11 / 1
Turnover
35.9%
buys $76.3M · sells $36.3M
Top-10 weight
71.6%

Biggest buys vs Q1 2019

ChangeSecurityShares changeChange %Est. trade value
AddedIntercept Pharmaceuticals Inc+140,489+1175.4%+$11.2M
NewCoherus Biosciences Inc+316,316–+$7.0M
NewAscendis Pharma A/S+60,266–+$6.9M
NewPacira BioSciences Inc+149,086–+$6.5M
AddedNeurocrine Biosciences Inc+68,340+284.3%+$5.8M
AddedInsmed Inc+186,478+65.6%+$4.8M
AddedSarepta Therapeutics Inc+29,047+136.6%+$4.4M
NewAbbVie Inc+52,681–+$3.8M
NewBiohaven Pharmaceutical Holdin+86,165–+$3.8M
AddedGlobal Blood Therapeutics Inc+55,206+63.4%+$2.9M
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2019

ChangeSecurityShares changeChange %Est. trade value
Sold outHeron Therapeutics Inc-388,623-100.0%$-9.5M
Sold outBausch Health Cos Inc-205,660-100.0%$-5.1M
Sold outStemline Therapeutics Inc-325,526-100.0%$-4.2M
Sold outNovartis AG-45,329-100.0%$-3.8M
Sold outCymabay Therapeutics Inc-210,257-100.0%$-2.8M
Sold outExelixis Inc-90,356-100.0%$-2.1M
Sold outAcorda Therapeutics Inc-154,806-100.0%$-2.1M
ReducedAllergan PLC-10,353-75.6%$-1.7M
Sold outKiniksa Pharmaceuticals Ltd-67,692-100.0%$-1.2M
Sold outChiasma Inc-203,948-100.0%$-1.1M
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $70.5MQ1 2016: $96.5MQ2 2016: $115.5MQ3 2016: $162.7MQ4 2016: $170.6MQ1 2017: $196.0MQ2 2017: $229.5MQ3 2017: $388.7MQ4 2017: $542.4MQ1 2018: $607.3MQ2 2018: $645.9MQ3 2018: $521.8MQ4 2018: $242.6MQ1 2019: $82.4MQ2 2019: $120.1M
Q4 2015Q2 2019

Holdings · Q2 2019

#SecuritySharesValueWeight
1Intercept Pharmaceuticals IncCOM152,441$12.1M10.10%
2Insmed IncCOM PAR $.01470,741$12.1M10.04%
3Audentes Therapeutics IncCOM294,013$11.1M9.27%
4Neurocrine Biosciences IncCOM92,380$7.8M6.50%
5Sarepta Therapeutics IncCOM50,317$7.6M6.37%
6Global Blood Therapeutics IncCOM142,305$7.5M6.23%
7Immunomedics IncCOM524,140$7.3M6.06%
8Coherus Biosciences IncCOM316,316$7.0M5.82%
9Ascendis Pharma A/SSPONSORED ADR60,266$6.9M5.78%
10Pacira BioSciences IncCOM149,086$6.5M5.40%
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.